Screener
SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$9.61M-45.5% | -$8.41M-44.6% | -$7.66M-13.7% | -$6.79M+4.5% | -$6.6M+11.6% | ||
| $1.02M+103% | $798K+58.0% | $447K+19.8% | $503K+32.0% | $501K+50.0% | ||
| -$7.59M-3.5% | -$8.85M+2.5% | -$4.92M+31.2% | -$7.07M+9.5% | -$7.33M+24.3% | ||
| $38.83M+818% | $44.15M+87.2% | $32.39M+404,825% | $26.09M+32.5% | $4.23M+922% | ||
| $31.25M— | $35.3M+143% | $27.47M— | $19.02M+60.1% | $0— |
FAQ
- How much cash does SELLAS Life Sciences Group, Inc. generate?
- SELLAS Life Sciences Group, Inc. (SLS) generated -$28.4M in operating cash flow over the trailing twelve months.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.